Insider · CIK 0001203240

MCLAUGHLIN JOHN

Reports to the SEC for 2 companies · BOULDER, CO

sec.gov

Transactions

Companies

Filings

CIK

0001203240

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-09	SNOASonoma Pharmaceuticals, Inc. · Stock option (right to buy)A Award	Director	AAward	+10K sh	—	—	30,001
2026-01-02	SNOASonoma Pharmaceuticals, Inc. · Stock option (right to buy)A Award	Director	AAward	+10K sh	—	—	20,001
2025-01-02	SNOASonoma Pharmaceuticals, Inc. · Stock option (right to buy)A Award	Director	AAward	+7,500 sh	—	—	10,044
2022-12-29	SNOASonoma Pharmaceuticals, Inc. · Stock option (right to buy)A Award	Director	AAward	+20K sh	—	—	53,252
2022-01-14	SNOASonoma Pharmaceuticals, Inc. · Stock option (right to buy)A Award	Director	AAward	+30K sh	—	—	33,252
2018-05-30	SNOASonoma Pharmaceuticals, Inc.A Award	Director	AAward	+1,781 sh	—	—	48,728
2018-03-01	SNOASonoma Pharmaceuticals, Inc.A Award	Director	AAward	+1,958 sh	—	—	46,947
2018-01-02	SNOASonoma Pharmaceuticals, Inc.A Award	Director	AAward	+17.2K sh	—	—	44,989
2017-11-29	SNOASonoma Pharmaceuticals, Inc.A Award	Director	AAward	+14.3K sh	—	—	27,778
2017-08-29	SNOASonoma Pharmaceuticals, Inc.A Award	Director	AAward	+1,210 sh	—	—	13,471
2017-05-30	SNOASonoma Pharmaceuticals, Inc.A Award	Director	AAward	+1,036 sh	—	—	12,261
2017-03-01	SNOASonoma Pharmaceuticals, Inc.A Award	Director	AAward	+976 sh	—	—	11,225
2017-02-28	SNOASonoma Pharmaceuticals, Inc.A Award	Director	AAward	+2,250 sh	—	—	10,249
2016-11-29	SNOASonoma Pharmaceuticals, Inc.A Award	Director	AAward	+1,423 sh	—	—	7,999
2016-08-29	SNOASonoma Pharmaceuticals, Inc.A Award	Director	AAward	+1,648 sh	—	—	6,576
2016-05-31	SNOASonoma Pharmaceuticals, Inc.A Award	Director	AAward	+6,765 sh	—	—	24,643
2016-02-29	SNOASonoma Pharmaceuticals, Inc.A Award	Director	AAward	+6,628 sh	—	—	6,628
2016-02-29	SNOASonoma Pharmaceuticals, Inc.A Award	Director	AAward	+11.3K sh	—	—	17,878
2015-11-30	SNOASonoma Pharmaceuticals, Inc. · Stock Options (Rights to Buy)A Award	Director	AAward	+7,488 sh	—	—	146,144
2015-08-31	SNOASonoma Pharmaceuticals, Inc. · Stock Options (Rights to Buy)A Award	Director	AAward	+7,774 sh	—	—	138,656
2015-06-01	SNOASonoma Pharmaceuticals, Inc. · Stock Options (Rights to Buy)A Award	Director	AAward	+10.6K sh	—	—	130,882
2015-03-02	SNOASonoma Pharmaceuticals, Inc. · Stock Options (right to buy)A Award	Director	AAward	+11K sh	—	—	120,272
2014-12-01	SNOASonoma Pharmaceuticals, Inc. · Stock Options (right to buy)A Award	Director	AAward	+6,773 sh	—	—	109,246
2014-10-01	SNOASonoma Pharmaceuticals, Inc. · Stock Options (right to buy)A Award	Director	AAward	+15K sh	—	—	102,473
2014-07-15	SNOASonoma Pharmaceuticals, Inc. · Stock Options (right to buy)A Award	Director	AAward	+3,455 sh	—	—	87,473
2014-03-04	SNOASonoma Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+55K sh	—	—	84,018
2013-12-18	SNOASonoma Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+6,150 sh	—	—	28,974
2013-10-01	SNOASonoma Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+2,143 sh	—	—	22,824
2013-09-19	SNOASonoma Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+5,351 sh	—	—	20,681
2013-09-06	SNOASonoma Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+8,187 sh	—	—	15,330
2007-06-29	COMPUMED INCnon-qualified stock optionsM Exercise/Conversion	Former President and CEO	MExercise/Conversion	−79.9K sh	$0.10	−$7,990	137,995
2007-06-29	COMPUMED INCS Sale	Former President and CEO	SSale	−79.9K sh	$0.59	−$47.3K	0
2007-06-29	COMPUMED INCM Exercise/Conversion	Former President and CEO	MExercise/Conversion	+79.9K sh	$0.10	+$7,990	79,900
2007-06-28	COMPUMED INCM Exercise/Conversion	Former President and CEO	MExercise/Conversion	+19K sh	$0.10	+$1,900	19,000
2007-06-28	COMPUMED INCS Sale	Former President and CEO	SSale	−19K sh	$0.59	−$11.2K	0
2007-06-28	COMPUMED INCnon-qualified stock optionsM Exercise/Conversion	Former President and CEO	MExercise/Conversion	−19K sh	$0.10	−$1,900	217,895
2007-06-27	COMPUMED INCM Exercise/Conversion	Former President and CEO	MExercise/Conversion	+3,105 sh	$0.10	+$310.5	3,105
2007-06-27	COMPUMED INCnon-qualified stock optionsM Exercise/Conversion	Former President and CEO	MExercise/Conversion	−3,105 sh	$0.10	−$310.5	236,895
2007-06-27	COMPUMED INCnon-qualified stock optionsM Exercise/Conversion	Former President and CEO	MExercise/Conversion	−4,395 sh	$0.08	−$351.6	0
2007-06-27	COMPUMED INCS Sale	Former President and CEO	SSale	−3,105 sh	$0.63	−$1,956.15	0
2007-06-27	COMPUMED INCS Sale	Former President and CEO	SSale	−4,395 sh	$0.63	−$2,768.85	0
2007-06-27	COMPUMED INCM Exercise/Conversion	Former President and CEO	MExercise/Conversion	+4,395 sh	$0.08	+$351.6	4,395
2007-06-26	COMPUMED INCS Sale	Former President and CEO	SSale	−9,100 sh	$0.63	−$5,733	0
2007-06-26	COMPUMED INCM Exercise/Conversion	Former President and CEO	MExercise/Conversion	+9,100 sh	$0.08	+$728	9,100
2007-06-26	COMPUMED INCnon-qualified stock optionsM Exercise/Conversion	Former President and CEO	MExercise/Conversion	−9,100 sh	$0.08	−$728	4,395
2007-06-19	COMPUMED INCnon-qualified stock optionsM Exercise/Conversion	Former President and CEO	MExercise/Conversion	−31.5K sh	$0.08	−$2,520	13,495
2007-06-19	COMPUMED INCM Exercise/Conversion	Former President and CEO	MExercise/Conversion	+31.5K sh	$0.08	+$2,520	31,500
2007-06-19	COMPUMED INCS Sale	Former President and CEO	SSale	−31.5K sh	$0.66	−$20.8K	31,500
2007-06-18	COMPUMED INCnon-qualified stock optionsM Exercise/Conversion	Former President and CEO	MExercise/Conversion	−50.5K sh	$0.08	−$4,040	44,995
2007-06-18	COMPUMED INCM Exercise/Conversion	Former President and CEO	MExercise/Conversion	+50.5K sh	$0.08	+$4,040	50,500

Recent filings

Accepted (ET)
Jul 94
MCLAUGHLIN JOHN0001683168-26-005421
SEC(opens sec.gov)
Jan 24
MCLAUGHLIN JOHN0001683168-26-000036
SEC(opens sec.gov)
Jan 34
MCLAUGHLIN JOHN0001683168-25-000082
SEC(opens sec.gov)
Dec 304
MCLAUGHLIN JOHN0001683168-22-008718
SEC(opens sec.gov)
Jan 144
MCLAUGHLIN JOHN0001683168-22-000277
SEC(opens sec.gov)
Jun 14
MCLAUGHLIN JOHN0001683168-18-001580
SEC(opens sec.gov)
Mar 24
MCLAUGHLIN JOHN0001683168-18-000569
SEC(opens sec.gov)
Jan 34
MCLAUGHLIN JOHN0001683168-18-000039
SEC(opens sec.gov)
Dec 14
MCLAUGHLIN JOHN0001683168-17-003206
SEC(opens sec.gov)
Aug 304
MCLAUGHLIN JOHN0001683168-17-002261
SEC(opens sec.gov)
Jun 14
Sonoma Pharmaceuticals, Inc.0001683168-17-001459
SEC(opens sec.gov)
Mar 24
Sonoma Pharmaceuticals, Inc.0001683168-17-000480
SEC(opens sec.gov)
Nov 304
Oculus Innovative Sciences, Inc.0001683168-16-000816
SEC(opens sec.gov)
Aug 304
Oculus Innovative Sciences, Inc.0001019687-16-007404
SEC(opens sec.gov)
Jun 14
Oculus Innovative Sciences, Inc.0001019687-16-006533
SEC(opens sec.gov)
Mar 24
Oculus Innovative Sciences, Inc.0001019687-16-005326
SEC(opens sec.gov)
Dec 24
Oculus Innovative Sciences, Inc.0001019687-15-004405
SEC(opens sec.gov)
Sep 24
Oculus Innovative Sciences, Inc.0001019687-15-003341
SEC(opens sec.gov)

Companies

Address

C/O SONOMA PHARMACEUTICALS, INC. 5445 CONESTOGA COURT, SUITE 150

BOULDER, CO, 80301